Lucintel's latest market report analyzed that pharmaceutical contract manufacturing provides attractive opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets. The pharmaceutical contract manufacturing market is expected to reach $222.0 billion by 2028 with a CAGR of 7.3%. In this market, biologics manufacturing is the largest segment by services, whereas big pharmaceutical is largest by end use industry.
Download Brochure of this report by clicking on https://www.lucintel.com/pharmaceutical-contract-manufacturing-market.aspx.
Based on services, the
pharmaceutical contract manufacturing market is segmented into manufacturing
[API, FDF (parenteral, injectable, tablet, capsule, and oral liquid)], drug
development, and biologics manufacturing. The biologics manufacturing segment accounted
for the largest share of the market in 2023 and is expected to register the
highest CAGR during the forecast period, due to increasing need for producing
vaccines and biosimilars.
Browse in-depth TOC on
“Pharmaceutical Contract Manufacturing Market”
100 – Figures/Tables
150 – Pages
The Pharmaceutical Contract
Manufacturing Market is marked by the presence of several big and small
players. Some of the prominent players offering pharmaceutical contract
manufacturing include Thermo Fisher Scientific, Catalent, Lonza, Almac Group,
Recipharm, Patheon, Grifols International, Dalton Pharma Services, and AbbVie.
Request Sample Report:
https://www.lucintel.com/pharmaceutical-contract-manufacturing-market.aspx
This unique research report will enable you
to make confident business decisions in this globally competitive marketplace. For
a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on
this link helpdesk@lucintel.com.
About Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related reports
Subcutaneous
Drug Delivery Device Market:
For more details click here https://www.lucintel.com/subcutaneous-drug-delivery-device-market.aspx
Orthopedic
Device Industry:
For more details click here https://www.lucintel.com/orthopedic-device-market.aspx
Respiratory Care Devices Market:
For more details click here https://www.lucintel.com/respiratory-care-device-market.aspx
Liquid Biopsy Market:
For more details click here https://www.lucintel.com/liquid-biopsy-market.aspx
Digital Fitness Market:
For more details click here https://www.lucintel.com/digital-fitness-market.aspx
Medical Device Market:
For more details click here https://www.lucintel.com/medical-device-market.aspx
Drug
Discovery Services Market:
For more details click here https://www.lucintel.com/drug-discovery-services-market.aspx
Medical Robot Market:
For more details click here https://www.lucintel.com/medical-robot-market.aspx
Medical
Lifting Sling Market:
For more details click here https://www.lucintel.com/medical-lifting-sling-market.aspx
Exosome Research Market:
No comments:
Post a Comment